Moderna Announces Potential Pricing for IPO
Transformative medicines company Moderna intends to price more than 21 million shares for an initial public offering valued up to $600 million.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 115
Short Sellers Hike Their Bets in Major Pharma Stocks
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Short Sellers Can’t Make Up Their Minds on Major Biotechs
The November 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Catabasis Wins With Early-Stage Duchenne Muscular Dystrophy Study
Catabasis Pharmaceuticals shares made a handy gain on Tuesday after the company announced early stage data from its Duchenne muscular dystrophy study.
Rocket Pharma Grounded Despite Positive FDA Update
Rocket Pharmaceuticals shares dipped on Tuesday after the company gave an update from the FDA. While the update wasn’t negative, this seems to be a case of sell the news, as the stock is…
Bristol-Myers Loses Out in Late-Stage Lung Cancer Study
Bristol-Myers Squibb shares dipped on Tuesday after the company reported results from its late-stage lung cancer study.
Why Wedbush Is Staying Positive on Zafgen
Despite this crushing loss where we saw shares down about 41% on Monday, one analyst is still positive on the stock.
Why Zafgen Shares Got Stomped
Zafgen shares were absolutely crushed on Monday after the company announced an update from the FDA.
Why One Top Drug Stock Could Have Nearly 30% Upside
Mallinckrodt has been a prominent player in the health care industry and while most analysts are taking a middle-of-the-road approach to the company, one has come out with a very bullish report.
Canaccord Genuity’s Top Biopharma Catalysts Coming This Quarter
Here 24/7 Wall St. takes a look at a recent report by Canaccord Genuity regarding to biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the rest of…
Seattle Genetics Dips Despite FDA Win
Seattle Genetics shares dipped on Monday following an update from the FDA on Adcetris for certain lymphomas.
Why Arena Pharma Is Winning Big With Its New Collaboration
Arena Pharmaceuticals shares jumped early on Thursday after the company announced a new global license agreement with United Therapeutics.
Synthorx Gears Up for IPO
Biopharmaceutical company Synthorx has filed with the SEC regarding its initial public offering.
Short Sellers Raise the Stakes in Major Biotechs
The October 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners
Here are five top health care stocks that provide investors with different avenues to invest in the sector. They all should be solid additions to growth portfolios for 2019.